ID

34601

Beschrijving

The I-KAN Study: Internet Insulin Education for Kansans; ODM derived from: https://clinicaltrials.gov/show/NCT01408628

Link

https://clinicaltrials.gov/show/NCT01408628

Trefwoorden

  1. 19-01-19 19-01-19 -
  2. 17-04-20 17-04-20 -
  3. 18-04-20 18-04-20 -
Houder van rechten

see on clinicaltrials.gov

Geüploaded op

19 januari 2019

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Type 2 Diabetes NCT01408628

Eligibility Type 2 Diabetes NCT01408628

Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
t2dm, meets provider criteria for insulin initiation; starting or having started insulin treatment no longer than six months prior to enrollment or has not yet committed to starting insulin but has agreed to participate in the education
Beschrijving

ID.1

Datatype

boolean

broadband internet and experience with logging into a password-protected site (e.g., ecommerce or social networking);
Beschrijving

ID.2

Datatype

boolean

ability to purchase or otherwise acquire glargine/detemir insulin and testing supplies.
Beschrijving

ID.3

Datatype

boolean

Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
use of oral glucocorticoids or second generation anti-psychotics;
Beschrijving

ID.4

Datatype

boolean

previous use of self-administered insulin more than six months prior to enrollment;
Beschrijving

ID.5

Datatype

boolean

gestational diabetes or other endocrine conditions causing hyperglycemia; treatment for a malignant condition other than basal cell carcinoma in situ within prior two years;
Beschrijving

ID.6

Datatype

boolean

renal insufficiency (ast/alt >2 or concurrent liver disease except nash);
Beschrijving

ID.7

Datatype

boolean

pregnant or planning to become pregnant within 6 months;
Beschrijving

ID.8

Datatype

boolean

hba1c < 7.0% or ongoing weight loss or persistent fasting hyperglycemia > 250 mg/dl.
Beschrijving

ID.9

Datatype

boolean

Similar models

Eligibility Type 2 Diabetes NCT01408628

Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
t2dm, meets provider criteria for insulin initiation; starting or having started insulin treatment no longer than six months prior to enrollment or has not yet committed to starting insulin but has agreed to participate in the education
boolean
ID.2
Item
broadband internet and experience with logging into a password-protected site (e.g., ecommerce or social networking);
boolean
ID.3
Item
ability to purchase or otherwise acquire glargine/detemir insulin and testing supplies.
boolean
Item Group
C0680251 (UMLS CUI)
ID.4
Item
use of oral glucocorticoids or second generation anti-psychotics;
boolean
ID.5
Item
previous use of self-administered insulin more than six months prior to enrollment;
boolean
ID.6
Item
gestational diabetes or other endocrine conditions causing hyperglycemia; treatment for a malignant condition other than basal cell carcinoma in situ within prior two years;
boolean
ID.7
Item
renal insufficiency (ast/alt >2 or concurrent liver disease except nash);
boolean
ID.8
Item
pregnant or planning to become pregnant within 6 months;
boolean
ID.9
Item
hba1c < 7.0% or ongoing weight loss or persistent fasting hyperglycemia > 250 mg/dl.
boolean

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial